Alban S, Kraus J, Franz G
Department of Pharmacy, University of Regensburg, Fed. Rep. of Germany.
Arzneimittelforschung. 1992 Aug;42(8):1005-8.
Laminarin sulfates were synthesized without significant degradation of the genuine laminarin chain using SO3/pyridine complex as a sulfation reagent. 6 derivatives with a degree of sulfation (d.s.) ranging from 0.30 to 2.26 could be obtained. According to methylation analysis the C-6-OH-groups of the glucose molecules were preferentially substituted, followed by the OH-groups at C-2 and C-4. The derivatives Lam S1 (d.s. = 0.30) and Lam S2 (d.s. = 0.64) showed no activity in the blood coagulation tests. With increasing d.s. the anticoagulant activity increased until an optimum d.s. of 1.49. Anticoagulant laminarin sulfates showed significant activity in the activated partial thromboplastin time (APTT) test but were less active in the anti-Factor Xa as well as anti-Factor IIa assay. Therefore, the anticoagulant activity of the synthesized laminarin sulfates is due to the interaction at an early stage of the coagulation cascade and neither to a direct inhibition of Factor Xa and IIa nor to an indirect effect mediated by antithrombin III.
以三氧化硫/吡啶络合物作为硫酸化试剂,在不显著降解天然海带多糖链的情况下合成了海带多糖硫酸盐。可以得到6种硫酸化程度(d.s.)范围为0.30至2.26的衍生物。根据甲基化分析,葡萄糖分子的C-6-OH基团优先被取代,其次是C-2和C-4位的OH基团。衍生物Lam S1(d.s. = 0.30)和Lam S2(d.s. = 0.64)在凝血试验中无活性。随着d.s.的增加,抗凝活性增加,直至最佳d.s.为1.49。抗凝海带多糖硫酸盐在活化部分凝血活酶时间(APTT)试验中表现出显著活性,但在抗Xa因子和抗IIa因子试验中的活性较低。因此,合成的海带多糖硫酸盐的抗凝活性是由于在凝血级联反应的早期阶段相互作用,而不是由于直接抑制Xa因子和IIa因子,也不是由于抗凝血酶III介导的间接作用。